OWCP (OWC Pharmaceutical Research) ROC %: -563.75% (As of Sep. 2019)


What is OWC Pharmaceutical Research ROC %?

OWC Pharmaceutical Research OWCP -90.00% ROC % is -563.75% as of Sep. 2019.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. OWC Pharmaceutical Research's annualized return on capital (ROC %) for the quarter that ended in Sep. 2019 was -563.75%.

As of today (2026-06-25), OWC Pharmaceutical Research's WACC % is 0.00%. OWC Pharmaceutical Research's ROC % is 0.00% (calculated using TTM income statement data). OWC Pharmaceutical Research earns returns that do not match up to its cost of capital. It will destroy value as it grows.

OWC Pharmaceutical Research  (OTCPK:OWCP) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, OWC Pharmaceutical Research's WACC % is 0.00%. OWC Pharmaceutical Research's ROC % is 0.00% (calculated using TTM income statement data). OWC Pharmaceutical Research earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

OWC Pharmaceutical Research ROC % Related Terms

OWC Pharmaceutical Research ROC % Historical Data

* Premium members only.

The historical data trend for OWC Pharmaceutical Research's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OWC Pharmaceutical Research ROC % Chart

OWC Pharmaceutical Research Annual Data
Trend Dec08 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
ROC %
Get a 7-Day Free Trial Premium Member Only -8,989.29 -2,501.52 -1,645.49 -2,265.67 -1,372.52

OWC Pharmaceutical Research Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,098.97 -2,321.38 -765.77 -609.16 -563.75

OWC Pharmaceutical Research ROC % Calculation

OWC Pharmaceutical Research's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2018 is calculated as:

ROC % (A: Dec. 2018 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2017 ) + Invested Capital (A: Dec. 2018 ))/ count )
=-4.296 * ( 1 - 0% )/( (0.249 + 0.377)/ 2 )
=-4.296/0.313
=-1,372.52 %

where

Invested Capital(A: Dec. 2017 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1.061 - 0.037 - ( 0.971 - max(0, 0.27 - 1.045+0.971))
=0.249

Invested Capital(A: Dec. 2018 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3.553 - 0.098 - ( 3.464 - max(0, 0.438 - 3.516+3.464))
=0.377

OWC Pharmaceutical Research's annualized Return on Capital (ROC %) for the quarter that ended in Sep. 2019 is calculated as:

ROC % (Q: Sep. 2019 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2019 ) + Invested Capital (Q: Sep. 2019 ))/ count )
=-2.348 * ( 1 - 0% )/( (0.498 + 0.335)/ 2 )
=-2.348/0.4165
=-563.75 %

where

Invested Capital(Q: Jun. 2019 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2.335 - 0.104 - ( 1.84 - max(0, 0.516 - 2.249+1.84))
=0.498

Invested Capital(Q: Sep. 2019 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1.773 - 0.286 - ( 1.465 - max(0, 0.543 - 1.695+1.465))
=0.335

Note: The Operating Income data used here is four times the quarterly (Sep. 2019) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -563.75% mean?
OWC Pharmaceutical Research (OWCP) has a ROC % of -563.75% as of Sep. 2019. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on OWC Pharmaceutical Research and its competitors.
Is OWC Pharmaceutical Research's ROC % too high?
OWC Pharmaceutical Research's current ROC % is -563.75%.
How does OWC Pharmaceutical Research's ROC % compare to PARNF and CANB?
OWC Pharmaceutical Research's ROC % of -563.75% can be compared against companies in the Drug Manufacturers industry. The industry median ROC % is 4.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Drug Manufacturers company?
The median ROC % among Drug Manufacturers companies is 4.44, based on 985 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on OWC Pharmaceutical Research and its competitors. For the Drug Manufacturers industry, the median ROC % is 4.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OWC Pharmaceutical Research's current ROC % is -563.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OWC Pharmaceutical Research stock overvalued right now?
OWC Pharmaceutical Research (OWCP) has a current ROC % of -563.75%. The current ROC % is -563.75%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For OWC Pharmaceutical Research (OWCP), the current ROC % is -563.75% as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OWC Pharmaceutical Research Business Description

Address 2 Ben Gurion Street, Ramat Gan, ISR, 4514760
OWC Pharmaceutical Research Corp is a medical cannabis research and development company. The firm through its subsidiary researches and develops cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder (PTSD), migraine, sexual function and skin disorders. It also provides consulting services to governmental and private entities to assist them with developing and implementing tailor-made medical cannabis program.